Jamaican Medical Cannabis Corporation (JMCC) has acquired several assets held by Materia Ventures in Malta. Materia Ventures is a cannabis and CBD products supply and distribution firm focused on Europe. Among the assets acquired by JMCC is a medical production facility certified by the European Union-Good Manufacturing Practices (EU-GMP) and in compliance with the minimum standard required for a manufacturer of medicines in order to be offered for sale in European markets.
Renaming of the Malta Unit
The JMCC, which is based both in Toronto, Canada, and in Jamaica, will rename the Malta operation JMCC Life Sciences, Europe. The privately owned businesses did not disclose the price of the acquisition, which includes Materia’s 32,000-square-foot Malta processing and manufacturing facility.
